Pacific Biosciences of California Inc’s recently made public that its insider Eidel Jeff unloaded Company’s shares for reported $42602.0 on Aug 19 ’24. In the deal valued at $1.59 per share,26,760 shares were sold. As a result of this transaction, Eidel Jeff now holds 869,730 shares worth roughly $1.57 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Van Oene Mark sold 38,011 shares, generating $63,174 in total proceeds. Upon selling the shares at $1.66, the insider now owns 1,630,815 shares.
Before that, JEFFREY EIDEL bought 26,760 shares. Pacific Biosciences of California Inc shares valued at $42,589 were divested by the Officer at a price of $1.59 per share.
A number of analysts have revised their coverage, including JP Morgan’s analysts, who decreased its forecast for the stock in late April from “an Overweight” to “a Neutral”. Goldman also remained covering PACB and has decreased its forecast on April 18, 2024 with a “Neutral” recommendation from previously “Buy” rating. Stephens started covering the stock on December 14, 2023. It rated PACB as “an Overweight”.
Price Performance Review of PACB
On Friday, Pacific Biosciences of California Inc [NASDAQ:PACB] saw its stock jump 0.56% to $1.81. Over the last five days, the stock has gained 14.56%. Pacific Biosciences of California Inc shares have fallen nearly -81.55% since the year began. Nevertheless, the stocks have fallen -84.56% over the past one year. While a 52-week high of $11.95 was reached on 01/02/24, a 52-week low of $1.16 was recorded on 07/02/24. SMA at 50 days reached $1.6314, while 200 days put it at $3.9084.
Levels Of Support And Resistance For PACB Stock
The 24-hour chart illustrates a support level at 1.7233, which if violated will result in even more drops to 1.6367. On the upside, there is a resistance level at 1.9533. A further resistance level may holdings at 2.0967. The Relative Strength Index (RSI) on the 14-day chart is 59.84, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.2290, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 27.03%. Stochastics %K at 76.80% indicates the stock is a holding.
How much short interest is there in Pacific Biosciences of California Inc?
A steep rise in short interest was recorded in Pacific Biosciences of California Inc stocks on 2024-08-30, growing by 3.92 million shares to a total of 61.03 million shares. Yahoo Finance data shows the prior-month short interest on 2024-07-31 was 57.1 million shares. There was a rise of 6.43%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on December 14, 2023 when Guggenheim began covering the stock and recommended ‘”a Neutral”‘ rating .
